Trevi Therapeutics, Inc. (TRVI) forecast

Trevi Therapeutics, Inc. (TRVI) forecast: price $12.85, trailing P/E -37.98, forward P/E n/a. How to read the street's path.

The live TRVI price is $12.85. Trailing P/E is -37.98 and forward P/E is n/a. The forecast that matters is the earnings path those ratios imply, not a single target price.

A forward P/E below the trailing P/E means the consensus expects earnings to rise. The reverse means the market is looking at a peak. Neither is a schedule. Analyst targets are useful as a range of models. They are not a contract. Discounted cash flow is the long form: cash flows, a discount rate, and a terminal value you can argue with.

Use this page for the TRVI forecast URL. The prediction page next to it puts the same live inputs in the price-target framing. Both stay in sync with the quote on the main page.

Learn: Forward P/E · Analyst forecast · DCF

Full TRVI quote · Dividends · Price prediction · Academy

Questions